实用心脑肺血管病杂志
實用心腦肺血管病雜誌
실용심뇌폐혈관병잡지
PRACTICAL JOURNAL OF CARDIAC CEREBRAL PNEUMAL AND VASCULAR DISEASE
2014年
7期
12-14
,共3页
肺疾病,慢性阻塞性%乙酰半胱氨酸%生活质量%呼吸功能试验
肺疾病,慢性阻塞性%乙酰半胱氨痠%生活質量%呼吸功能試驗
폐질병,만성조새성%을선반광안산%생활질량%호흡공능시험
Pulmonary disease,chronic obstructive%Acetylcysteine%Quality of life%Respiratory function tests
目的:观察乙酰半胱氨酸对稳定期慢性阻塞性肺疾病( COPD)患者急性加重率及生活质量的影响。方法选择2012年4月-2013年8月在鄂尔多斯市中心医院门诊就诊的稳定期 COPD 患者86例,随机分为治疗组43例和对照组43例。对照组给予常规治疗,治疗组在常规治疗的基础上加用乙酰半胱氨酸。观察两组患者肺功能指标、急性加重情况,并采用中文版 COPD 评估测试(CAT)问卷评价其生活质量。结果两组患者治疗前及治疗后6、12个月第一秒用力呼气容积(FEV1)、FEV1占预计值百分比(FEV1%)、FEV1/用力肺活量(FVC)比较,差异均无统计学意义(P >0.05)。治疗前,两组患者中文版 CAT 问卷总分比较,差异无统计学意义( P >0.05);治疗后6、12个月,治疗组患者中文版 CAT 问卷总分低于对照组,差异均有统计学意义(P <0.05)。治疗前及治疗6个月后,两组患者急性加重率比较,差异均无统计学意义(P >0.05);治疗12个月后,治疗组急性加重率低于对照组,差异有统计学意义(P <0.05)。结论长期口服乙酰半胱氨酸可减少 COPD 患者急性加重率,改善其生活质量。
目的:觀察乙酰半胱氨痠對穩定期慢性阻塞性肺疾病( COPD)患者急性加重率及生活質量的影響。方法選擇2012年4月-2013年8月在鄂爾多斯市中心醫院門診就診的穩定期 COPD 患者86例,隨機分為治療組43例和對照組43例。對照組給予常規治療,治療組在常規治療的基礎上加用乙酰半胱氨痠。觀察兩組患者肺功能指標、急性加重情況,併採用中文版 COPD 評估測試(CAT)問捲評價其生活質量。結果兩組患者治療前及治療後6、12箇月第一秒用力呼氣容積(FEV1)、FEV1佔預計值百分比(FEV1%)、FEV1/用力肺活量(FVC)比較,差異均無統計學意義(P >0.05)。治療前,兩組患者中文版 CAT 問捲總分比較,差異無統計學意義( P >0.05);治療後6、12箇月,治療組患者中文版 CAT 問捲總分低于對照組,差異均有統計學意義(P <0.05)。治療前及治療6箇月後,兩組患者急性加重率比較,差異均無統計學意義(P >0.05);治療12箇月後,治療組急性加重率低于對照組,差異有統計學意義(P <0.05)。結論長期口服乙酰半胱氨痠可減少 COPD 患者急性加重率,改善其生活質量。
목적:관찰을선반광안산대은정기만성조새성폐질병( COPD)환자급성가중솔급생활질량적영향。방법선택2012년4월-2013년8월재악이다사시중심의원문진취진적은정기 COPD 환자86례,수궤분위치료조43례화대조조43례。대조조급여상규치료,치료조재상규치료적기출상가용을선반광안산。관찰량조환자폐공능지표、급성가중정황,병채용중문판 COPD 평고측시(CAT)문권평개기생활질량。결과량조환자치료전급치료후6、12개월제일초용력호기용적(FEV1)、FEV1점예계치백분비(FEV1%)、FEV1/용력폐활량(FVC)비교,차이균무통계학의의(P >0.05)。치료전,량조환자중문판 CAT 문권총분비교,차이무통계학의의( P >0.05);치료후6、12개월,치료조환자중문판 CAT 문권총분저우대조조,차이균유통계학의의(P <0.05)。치료전급치료6개월후,량조환자급성가중솔비교,차이균무통계학의의(P >0.05);치료12개월후,치료조급성가중솔저우대조조,차이유통계학의의(P <0.05)。결론장기구복을선반광안산가감소 COPD 환자급성가중솔,개선기생활질량。
Objective To evaluate the effect of acetylcysteine on acute exacerbation rate and quality of life in patients with chronic obstructive pulmonary disease( COPD). Methods From April 2012 to August,65 stable COPD outpatients in Central Hospital of Odors were chosen,and they were randomly divided into treatment group and control group,each of 43 ca-ses. Control group was given routine treatment,while treatment group was given acetylcysteine on the basis of routine treat-ment. The lung function,acute exacerbation rate of COPD were recorded,and the quality of life was assessed by Chinese - CAT questionnaire. Results There was no significant differences in FEV1 ,FEV1% ,FEV1 / FVC between the two groups before treatment and 6,12 months after treatment. Before treatment,there was no significant differences in total score of Chinese -CAT questionnaire between the two groups,but the total score of Chinese - CAT questionnaire of treatment group was lower than that of control group after treatment of 6,12 months. Before treatment and 6 months after treatment,there was no significant differences in acute exacerbation rate between the two groups,but the acute exacerbation rate of treatment group was lower than that of control group after treatment of 12 months. Conclusion Taking long - term oral acetylcysteine can reduce the acute exac-erbation rate of COPD,improve the quality of life of stable COPD patients.